BIOVASCULAR

biovascular-logo

BioVascular is a clinical stage privately held biotechnology company developing รขโ‚ฌล“first in classรขโ‚ฌย products for platelet mediated cardiovascular diseases. BioVascularรขโ‚ฌโ„ขs initial product, saratin, is a polypeptide produced by recombinant means in yeast. This product was discovered by and licensed from Merck KGaA. BioVascular is conducting human clinical trials of saratin for use in hemodialysis access graft and peripheral artery grafts to reduce intimal hyperplasia, which can lead to failure of the graft.

#People #Financial #Website #More

BIOVASCULAR

Industry:
Biotechnology Health Diagnostics Medical

Founded:
2006-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.biovascularinc.com

Total Employee:
1+

Status:
Active

Contact:
858-455-5000

Email Addresses:
[email protected]

Total Funding:
10.87 M USD

Technology used in webpage:
Nginx GoDaddy SSL Shockwave Flash Embed Nginx 1.16 Intermedia Media Temple MediaTemple DNS



Current Advisors List

martin-mรผnchbach_image

Martin Mรผnchbach Board of Directors @ BioVascular
Board_member

Investors List

bb-biotech-ventures_image

BB Biotech Ventures

BB Biotech Ventures investment in Series C - BioVascular

domain-associates_image

Domain Associates

Domain Associates investment in Series C - BioVascular

merck-kgaa_image

Merck

Merck investment in Series C - BioVascular

Official Site Inspections

http://www.biovascularinc.com

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 15.197.148.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "BioVascular" on Search Engine